As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer ...
With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.
Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three ...
MiniMed completed its separation from Medtronic, the companies said Thursday. The diabetes technology firm, which went public ...
Chief commercial officer, EndoQuest Robotics. Previous title: Vice president of robotics, AI and neuroscience, HCA Healthcare ...
The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare ...
Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.
Zimmer distributes an exclusive version of Think’s wireless handheld miniature robotic system that works with its Persona ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results